Vertex Pharmaceuticals
VRTX
VRTX
500 hedge funds and large institutions have $28.5B invested in Vertex Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 185 increasing their positions, 181 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
35% less call options, than puts
Call options by funds: $86.7M | Put options by funds: $134M
Holders
500
Holding in Top 10
4
Calls
$86.7M
Puts
$134M
Top Buyers
| 1 | +$140M | |
| 2 | +$65.3M | |
| 3 | +$61.8M | |
| 4 |
CCM
Cornerstone Capital Management
Edina,
Minnesota
|
+$60.6M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$60.3M |
Top Sellers
| 1 | -$187M | |
| 2 | -$182M | |
| 3 | -$180M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$94.6M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$81.7M |